Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating PVNS with anti-CSF1R antibodies

Method of treating PVNS with anti-CSF1R antibodies

US Patent 10730949 · Granted Aug 4, 2020

Estimated economic value: $5,225,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of making afucosylated anti-FGFR2IIIB antibodies2025
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
FGFR2 inhibitors alone or in combination with immune stimulating agents in cance2022
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Afucosylated anti-FGFR2IIIB antibodies2022
Methods of treating conditions with antibodies that bind colony stimulating fact2021
Methods of treating conditions with antibodies that bind colony stimulating fact2021
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer2020
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer2020
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer2019